PT  - JOURNAL ARTICLE
AU  - Gross, Rachel
AU  - Thaweethai, Tanayott
AU  - Rosenzweig, Erika B.
AU  - Chan, James
AU  - Chibnik, Lori B.
AU  - Cicek, Mine S.
AU  - Elliott, Amy J.
AU  - Flaherman, Valerie J.
AU  - Foulkes, Andrea S.
AU  - Witvliet, Margot Gage
AU  - Gallagher, Richard
AU  - Gennaro, Maria Laura
AU  - Jernigan, Terry L.
AU  - Karlson, Elizabeth W.
AU  - Katz, Stuart D.
AU  - Kinser, Patricia A.
AU  - Kleinman, Lawrence C.
AU  - Lamendola-Essel, Michelle F.
AU  - Milner, Joshua D.
AU  - Mohandas, Sindhu
AU  - Mudumbi, Praveen C.
AU  - Newburger, Jane W.
AU  - Rhee, Kyung E.
AU  - Salisbury, Amy L.
AU  - Snowden, Jessica N.
AU  - Stein, Cheryl R.
AU  - Stockwell, Melissa S.
AU  - Tantisira, Kelan G.
AU  - Thomason, Moriah E.
AU  - Truong, Dongngan T.
AU  - Warburton, David
AU  - Wood, John C.
AU  - Ahmed, Shifa
AU  - Akerlundh, Almary
AU  - Alshawabkeh, Akram N.
AU  - Anderson, Brett R.
AU  - Aschner, Judy L.
AU  - Atz, Andrew M.
AU  - Aupperle, Robin L.
AU  - Baker, Fiona C.
AU  - Balaraman, Venkataraman
AU  - Banerjee, Dithi
AU  - Barch, Deanna M.
AU  - Baskin-Sommers, Arielle
AU  - Bhuiyan, Sultana
AU  - Bind, Marie-Abele C.
AU  - Bogie, Amanda L.
AU  - Buchbinder, Natalie C.
AU  - Bueler, Elliott
AU  - Bükülmez, Hülya
AU  - Casey, B.J.
AU  - Chang, Linda
AU  - Clark, Duncan B.
AU  - Clifton, Rebecca G.
AU  - Clouser, Katharine N.
AU  - Cottrell, Lesley
AU  - Cowan, Kelly
AU  - D’Sa, Viren
AU  - Dapretto, Mirella
AU  - Dasgupta, Soham
AU  - Dehority, Walter
AU  - Dummer, Kirsten B.
AU  - Elias, Matthew D.
AU  - Esquenazi-Karonika, Shari
AU  - Evans, Danielle N.
AU  - Faustino, E. Vincent S.
AU  - Fiks, Alexander G.
AU  - Forsha, Daniel
AU  - Foxe, John J.
AU  - Friedman, Naomi P.
AU  - Fry, Greta
AU  - Gaur, Sunanda
AU  - Gee, Dylan G.
AU  - Gray, Kevin M.
AU  - Harahsheh, Ashraf S.
AU  - Heath, Andrew C.
AU  - Heitzeg, Mary M.
AU  - Hester, Christina M.
AU  - Hill, Sophia
AU  - Hobart-Porter, Laura
AU  - Hong, Travis K.F.
AU  - Horowitz, Carol R.
AU  - Hsia, Daniel S.
AU  - Huentelman, Matthew
AU  - Hummel, Kathy D.
AU  - Iacono, William G.
AU  - Irby, Katherine
AU  - Jacobus, Joanna
AU  - Jacoby, Vanessa L.
AU  - Jone, Pei-Ni
AU  - Kaelber, David C.
AU  - Kasmarcak, Tyler J.
AU  - Kluko, Matthew J.
AU  - Kosut, Jessica S.
AU  - Laird, Angela R.
AU  - Landeo-Gutierrez, Jeremy
AU  - Lang, Sean M.
AU  - Larson, Christine L.
AU  - Lim, Peter Paul C.
AU  - Lisdahl, Krista M.
AU  - McCrindle, Brian W.
AU  - McCulloh, Russell J.
AU  - Mendelsohn, Alan L.
AU  - Metz, Torri D.
AU  - Morgan, Lerraughn M.
AU  - Müller-Oehring, Eva M.
AU  - Nahin, Erica R.
AU  - Neale, Michael C.
AU  - Ness-Cochinwala, Manette
AU  - Nolan, Sheila M.
AU  - Oliveira, Carlos R.
AU  - Oster, Matthew E.
AU  - Payne, R. Mark
AU  - Raissy, Hengameh
AU  - Randall, Isabelle G.
AU  - Rao, Suchitra
AU  - Reeder, Harrison T.
AU  - Rosas, Johana M.
AU  - Russell, Mark W.
AU  - Sabati, Arash A.
AU  - Sanil, Yamuna
AU  - Sato, Alice I.
AU  - Schechter, Michael S.
AU  - Selvarangan, Rangaraj
AU  - Shakti, Divya
AU  - Sharma, Kavita
AU  - Squeglia, Lindsay M.
AU  - Stevenson, Michelle D.
AU  - Szmuszkovicz, Jacqueline
AU  - Talavera-Barber, Maria M.
AU  - Teufel, Ronald J.
AU  - Thacker, Deepika
AU  - Udosen, Mmekom M.
AU  - Warner, Megan R.
AU  - Watson, Sara E.
AU  - Werzberger, Alan
AU  - Weyer, Jordan C.
AU  - Wood, Marion J.
AU  - Yin, H. Shonna
AU  - Zempsky, William T.
AU  - Zimmerman, Emily
AU  - Dreyer, Benard P.
AU - the RECOVER Initiative
TI  - Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design
AID  - 10.1101/2023.04.27.23289228
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.04.27.23289228
4099  - http://medrxiv.org/content/early/2023/05/12/2023.04.27.23289228.short
4100  - http://medrxiv.org/content/early/2023/05/12/2023.04.27.23289228.full
AB  - Importance The prevalence, pathophysiology, and long-term outcomes of COVID-19 (post-acute sequelae of SARS-CoV-2 [PASC] or “Long COVID”) in children and young adults remain unknown. Studies must address the urgent need to define PASC, its mechanisms, and potential treatment targets in children and young adults.Observations We describe the protocol for the Pediatric Observational Cohort Study of the NIH’s REsearching COVID to Enhance Recovery (RECOVER) Initiative. RECOVER-Pediatrics is an observational meta-cohort study of caregiver-child pairs (birth through 17 years) and young adults (18 through 25 years), recruited from more than 100 sites across the US. This report focuses on two of five cohorts that comprise RECOVER-Pediatrics: 1) a de novo RECOVER prospective cohort of children and young adults with and without previous or current infection; and 2) an extant cohort derived from the Adolescent Brain Cognitive Development (ABCD) study (n=10,000). The de novo cohort incorporates three tiers of data collection: 1) remote baseline assessments (Tier 1, n=6000); 2) longitudinal follow-up for up to 4 years (Tier 2, n=6000); and 3) a subset of participants, primarily the most severely affected by PASC, who will undergo deep phenotyping to explore PASC pathophysiology (Tier 3, n=600). Youth enrolled in the ABCD study participate in Tier 1. The pediatric protocol was developed as a collaborative partnership of investigators, patients, researchers, clinicians, community partners, and federal partners, intentionally promoting inclusivity and diversity. The protocol is adaptive to facilitate responses to emerging science.Conclusions and Relevance RECOVER-Pediatrics seeks to characterize the clinical course, underlying mechanisms, and long-term effects of PASC from birth through 25 years old. RECOVER-Pediatrics is designed to elucidate the epidemiology, four-year clinical course, and sociodemographic correlates of pediatric PASC. The data and biosamples will allow examination of mechanistic hypotheses and biomarkers, thus providing insights into potential therapeutic interventions.Clinical Trials.gov Identifier Clinical Trial Registration: http://www.clinicaltrials.gov. Unique identifier: NCT05172011Competing Interest StatementI have read the journal's policy and the authors of this manuscript have the following competing interests: Brett Anderson reported receiving direct support for work not related to RECOVER work/publications from Genentech and the National Institute of Allergy and Immunology. Walter Dehority reported receiving grant support from Merck and participating in research for the Moderna COVID-19 pediatric vaccine trial and the Pfizer Paxlovid trial. Alex Fiks reported receiving support from NJM insurance and personal consulting fees not related to this paper from Rutgers University and the American Academy of Pediatrics. Ashraf Harahsheh reported serving as a scientific advisory board member unrelated to this paper for OP2 DRUGS. Lawrence Kleinman reported serving as an unpaid member of the Board of Directors for the DARTNet Institute, as a principle investigator at Quality Matters, Inc., and as the Vice Chair for the Borough of Metuchen Board of Health. Dr. Kleinman also reported grant support for work not related to RECOVER work/publications from NIH, HRSA, and the Robert Wood Johnson Foundation. Dr. Kleinman also reported minority individual stock ownership in Apple Computer, Sanofi SA, Experion, GlaxoSmithKline, Magyar Bank, Regeneron Pharmaceuticals, JP Morgan Chase, and Amgen Inc. Torri Metz reported participating as a Principle Investigator in the medical advisory board for the planning of a Pfizer clinical trial of SARS-CoV-2 vaccination in pregnancy. She is also a principle investigator for a Pfizer study evaluating the pharmacokinetics of Paxlovid in pregnant people with COVID-19. Joshua Milner reported serving as a member of the Scientific Advisory Board for Blueprint Medicines, in a capacity unrelated to RECOVER work/publications.Clinical Protocols https://recovercovid.org/sites/default/files/docs/PediatricProtocol.v2.3.pdf Funding StatementNational Institutes of Health (NIH) Agreement OTA OT2HL161847 (SDK, RG), OT2HL161841 (ASF). https://www.nih.gov/ The funders did not and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of NYU Grossman School of Medicine gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesNo datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.